Beta-blockers

Off-label use in psychiatric disorders

William J. Newman, Glen Xiong, Amy V Barnhorst

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Psychiatrists have long prescribed beta-blockers in various clinical situations. Although many uses are well established in psychiatric practice, they are all offlabel indications. The term "off-label" refers to the use of an existing medication for purposes other than those specifically approved by the FDA. Off-label prescriptions are common throughout medicine and are entirely legal. They may, however, be viewed with additional scrutiny in the event of a lawsuit involving a negative treatment outcome.

Original languageEnglish (US)
Pages (from-to)73-80
Number of pages8
JournalPsychopharm Review
Volume48
Issue number10
DOIs
StatePublished - 2013

Fingerprint

Off-Label Use
Psychiatry
Forensic Medicine
Prescriptions

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Beta-blockers : Off-label use in psychiatric disorders. / Newman, William J.; Xiong, Glen; Barnhorst, Amy V.

In: Psychopharm Review, Vol. 48, No. 10, 2013, p. 73-80.

Research output: Contribution to journalArticle

Newman, William J. ; Xiong, Glen ; Barnhorst, Amy V. / Beta-blockers : Off-label use in psychiatric disorders. In: Psychopharm Review. 2013 ; Vol. 48, No. 10. pp. 73-80.
@article{3e335426dcbc4e79a34b51317c726bfb,
title = "Beta-blockers: Off-label use in psychiatric disorders",
abstract = "Psychiatrists have long prescribed beta-blockers in various clinical situations. Although many uses are well established in psychiatric practice, they are all offlabel indications. The term {"}off-label{"} refers to the use of an existing medication for purposes other than those specifically approved by the FDA. Off-label prescriptions are common throughout medicine and are entirely legal. They may, however, be viewed with additional scrutiny in the event of a lawsuit involving a negative treatment outcome.",
author = "Newman, {William J.} and Glen Xiong and Barnhorst, {Amy V}",
year = "2013",
doi = "10.1097/01.PSYPHR.0000436763.15959.dc",
language = "English (US)",
volume = "48",
pages = "73--80",
journal = "Psychopharm Review",
issn = "1936-9255",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Beta-blockers

T2 - Off-label use in psychiatric disorders

AU - Newman, William J.

AU - Xiong, Glen

AU - Barnhorst, Amy V

PY - 2013

Y1 - 2013

N2 - Psychiatrists have long prescribed beta-blockers in various clinical situations. Although many uses are well established in psychiatric practice, they are all offlabel indications. The term "off-label" refers to the use of an existing medication for purposes other than those specifically approved by the FDA. Off-label prescriptions are common throughout medicine and are entirely legal. They may, however, be viewed with additional scrutiny in the event of a lawsuit involving a negative treatment outcome.

AB - Psychiatrists have long prescribed beta-blockers in various clinical situations. Although many uses are well established in psychiatric practice, they are all offlabel indications. The term "off-label" refers to the use of an existing medication for purposes other than those specifically approved by the FDA. Off-label prescriptions are common throughout medicine and are entirely legal. They may, however, be viewed with additional scrutiny in the event of a lawsuit involving a negative treatment outcome.

UR - http://www.scopus.com/inward/record.url?scp=84888381527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888381527&partnerID=8YFLogxK

U2 - 10.1097/01.PSYPHR.0000436763.15959.dc

DO - 10.1097/01.PSYPHR.0000436763.15959.dc

M3 - Article

VL - 48

SP - 73

EP - 80

JO - Psychopharm Review

JF - Psychopharm Review

SN - 1936-9255

IS - 10

ER -